← Back to Vaccine Database

GLS-5310

DNA based vaccine · VDDBV0304

Target & Classification

SARS-CoV-2SARS-CoV-2
DNA based vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials3

NCT IDPhaseDisease / Condition
NCT05085639 Phase 1COVID-19
NCT05182567 Phase 1COVID-19
NCT04673149 Phase 2COVID-19